Table 1 Participants’ demographic data (n = 70)
Variable | Value |
|---|---|
Age (years) | 49.4 ± 12.1 (24–81) |
Gender (F:M) | 40:30 |
Smoking | 8 (11.4%) |
Associated thyroid disease | |
Graves’ disease | 66 (94.3%) |
Hashimoto thyroiditis | 1 (1.4%) |
Hypothyroid | 1 (1.4%) |
None | 2 (2.8%) |
Current thyroid status | |
Hyperthyroid | 8 (11.4%) |
Hypothyroid | 6 (8.6%) |
Subclinical hyperthyroid | 4 (5.7%) |
Subclinical hypothyroid | 3 (4.3%) |
Euthyroid | 49 (70%) |
Treatment thyroid disease | |
< 1 treatment | 59 (84.3%) |
Antithyroid drug | 33 (47.1%) |
Radioiodine | 2 (2.9%) |
Thyroidectomy | 1 (1.4%) |
Thyroxine | 9 (12.9%) |
None | 14 (20.0%) |
> 1 treatments | 11 (15.7%) |
Antithyroid drug, radioiodine | 1 (1.4%) |
Thyroidectomy, antithyroid drug | 2 (2.9%) |
Thyroidectomy, thyroxine | 2 (2.9%) |
Radioiodine, thyroxine | 6 (8.5%) |
Other autoimmun | 2 (2.8%) |
Steroid treatment for GO | |
IVMP | 16 (37.2%) |
Oral steroid | 7 (16.3%) |
Orbitotomy | 20 (46.5%) |
Current symptoms | |
Orbital pain | 6 (5.9%) |
Pain on eye movement | 2 (1.9%) |
Dry eye | 37 (36.6%) |
Photophobia | 3 (2.9%) |
Watery | 7 (6.9%) |
Diplopia | 37 (36.6%) |
Blurred vision | 9 (8.9%) |
Active GO (CAS > 3) | 6 (8.6%) |
CAS | 1 ± 1.2 (0–5) |
GO severity by EUGOGO classification | |
Mild | 17 (24.3%) |
Moderate to severe | 47 (67.1%) |
Very severe (DON) | 6 (8.6%) |
Visual acuity (best corrected VA) | |
Right eye | 0.6 ± 0.2 (0–1) |
Left eye | 0.6 ± 0.2 (0.03–1) |
Exophthalmos (mm.) | |
Right eye | 18.0 ± 3.3 (10–25) |
Left eye | 18.2 ± 3.2 (9–25) |
Lid retraction (N = 44) | |
Upper lid (MRD1 minus 5) | 2.7 ± 0.64 |
Lower lid (from limbus) | 1.7 ± 0.93 |
Occupation | |
Agriculture | 6 (8.6%) |
Employer | 28 (40%) |
Employee | 15 (21.4%) |
Homemaker | 14 (20%) |
Retirement | 4 (5.7%) |
Not working related to eye condition | 2 (2.8%) |